百時美施貴寶購買輝達SuperPOD — 它真能加速藥物發現嗎？
百時美施貴寶購買了輝達dgx superpod用於藥物發現。此舉標誌著製藥行業競相將垂直ai整合到研發管道中。
bristol myers squibb is deploying an nvidia dgx superpod powered by the vera rubin architecture. the system aims to streamline artificial intelligence across its drug discovery and development workflows. it marks the first deployment of this architecture in the life sciences sector. this signals a shift from experimental ai tools to essential infrastructure for competitive biotech research.